Please enable Javascript

Labmeeting uses lots of Javascript - basically you can't use the site without it. So please enable Javascript in your browser. If your browser does not support Javascript, we recommend Firefox.

Papers authored by Gorse GJ

Collect these papers and discover other ones on Labmeeting. Learn more.

Randomized, double-blind controlled phase 3 trial comparing the immunogenicity of high-dose and standard-dose influenza vaccine in adults 65 years of age and older.

+ cite this

+ View Abstract

Falsey AR, Treanor JJ, Tornieporth N, Capellan J, and Gorse GJ

The Journal of infectious diseases 200(2):172-80, 2009 Jul 15 - Who cited this? | PubMed ID: 19508159 | Fulltext

Human coronavirus and acute respiratory illness in older adults with chronic obstructive pulmonary disease.

+ cite this

+ View Abstract

Gorse GJ, O'Connor TZ, Hall SL, Vitale JN, and Nichol KL

The Journal of infectious diseases 199(6):847-57, 2009 Mar 15 - Who cited this? | PubMed ID: 19239338 | Fulltext

Comparison of the Safety and Immunogenicity of 2 Respiratory Syncytial Virus (RSV) Vaccines- Nonadjuvanted Vaccine or Vaccine Adjuvanted with Alum-Given Concomitantly with Influenza Vaccine to High-Risk Elderly Individuals.

+ cite this

+ View Abstract

Falsey AR, Walsh EE, Capellan J, Gravenstein S, Zambon M, Yau E, Gorse GJ, Edelman R, Hayden FG, McElhaney JE, Neuzil KM, Nichol KL, Simões EA, Wright PF, and Sales VM

The Journal of infectious diseases 198(9):1317-1326, 2008 Nov 1 - Who cited this? | PubMed ID: 18855558 | Fulltext

Safety and immunogenicity of cytotoxic T-lymphocyte poly-epitope, DNA plasmid (EP HIV-1090) vaccine in healthy, human immunodeficiency virus type 1 (HIV-1)-uninfected adults.

+ cite this

+ View Abstract

Gorse GJ, Baden LR, Wecker M, Newman MJ, Ferrari G, Weinhold KJ, Livingston BD, Villafana TL, Li H, Noonan E, Russell ND, and HIV Vaccine Trials Network

Vaccine 26(2):215-23, 2008 Jan 10 - Who cited this? | PubMed ID: 18055072 | Fulltext

Response to letter to the editor "Zink TK. Vaccine 2007;25(15):2766-7".

+ cite this

Gorse GJ, Keitel W, Keyserling H, Taylor DN, Lock M, Alves K, Kenner J, Deans L, and Gurwith M

Vaccine 25(42):7285-7, 2007 Oct 16 - Who cited this? | PubMed ID: 17850932 | Fulltext

Impact of a winter respiratory virus season on patients with COPD and association with influenza vaccination.

+ cite this

+ View Abstract

Gorse GJ, O'Connor TZ, Young SL, Habib MP, Wittes J, Neuzil KM, and Nichol KL

Chest 130(4):1109, 2006 Oct - Who cited this? | PubMed ID: 17035445 | Fulltext

Immunogenicity and tolerance of ascending doses of a recombinant protective antigen (rPA102) anthrax vaccine: a randomized, double-blinded, controlled, multicenter trial.

+ cite this

+ View Abstract

Gorse GJ, Keitel W, Keyserling H, Taylor DN, Lock M, Alves K, Kenner J, Deans L, and Gurwith M

Vaccine 24(33-34):5950-9, 2006 Aug 14 - Who cited this? | PubMed ID: 16797805 | Fulltext

Cellular immune responses in asymptomatic human immunodeficiency virus type 1 (HIV-1) infection and effects of vaccination with recombinant envelope glycoprotein of HIV-1.

+ cite this

+ View Abstract

Gorse GJ, Simionescu RE, and Patel GB

Clinical and vaccine immunology : CVI 13(1):26-32, 2006 Jan - Who cited this? | PubMed ID: 16425996 | Fulltext

Recruitment and baseline epidemiologic profile of participants in the first phase 3 HIV vaccine efficacy trial.

+ cite this

+ View Abstract

Harro CD, Judson FN, Gorse GJ, Mayer KH, Kostman JR, Brown SJ, Koblin B, Marmor M, Bartholow BN, Popovic V, and VAX004 Study Group

Journal of acquired immune deficiency syndromes (1999) 37(3):1385-92, 2004 Nov 1 - Who cited this? | PubMed ID: 15483468 | Fulltext

Immunity to influenza in older adults with chronic obstructive pulmonary disease.

+ cite this

+ View Abstract

Gorse GJ, O'Connor TZ, Newman FK, Mandava MD, Mendelman PM, Wittes J, and Peduzzi PN

The Journal of infectious diseases 190(1):11-9, 2004 Jul 1 - Who cited this? | PubMed ID: 15195238 | Fulltext

Comparison of systemic and mucosal delivery of 2 canarypox virus vaccines expressing either HIV-1 genes or the gene for rabies virus G protein.

+ cite this

+ View Abstract

Wright PF, Mestecky J, McElrath MJ, Keefer MC, Gorse GJ, Goepfert PA, Moldoveanu Z, Schwartz D, Spearman PW, El Habib R, Spring MD, Zhu Y, Smith C, Flores J, Weinhold KJ, and National Institutes of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group

The Journal of infectious diseases 189(7):1221-31, 2004 Apr 1 - Who cited this? | PubMed ID: 15031791 | Fulltext

Binding of antibodies to human immunodeficiency virus type 1 (HIV-1)-infected lymphocytes elicited by vaccines and by natural infection.

+ cite this

+ View Abstract

Gorse GJ, Patel GB, Arbuckle JA, and Belshe RB

Vaccine 22(3-4):383-97, 2004 Jan 2 - Who cited this? | PubMed ID: 14670320 | Fulltext

Efficacy trial of live, cold-adapted and inactivated influenza virus vaccines in older adults with chronic obstructive pulmonary disease: a VA cooperative study.

+ cite this

+ View Abstract

Gorse GJ, O'Connor TZ, Young SL, Mendelman PM, Bradley SF, Nichol KL, Strickland JH, Paulson DM, Rice KL, Foster RA, Fulambarker AM, Shigeoka JW, Kuschner WG, Goodman RP, Neuzil KM, Wittes J,

(show remaining authors)

Vaccine 21(17-18):2133-44, 2003 May 16 - Who cited this? | PubMed ID: 12706704 | Fulltext

Recognizing influenza in older patients with chronic obstructive pulmonary disease who have received influenza vaccine.

+ cite this

+ View Abstract

Neuzil KM, O'Connor TZ, Gorse GJ, and Nichol KL

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 36(2):169-74, 2003 Jan 15 - Who cited this? | PubMed ID: 12522748 | Fulltext

Safety and immunogenicity of a high-titered canarypox vaccine in combination with rgp120 in a diverse population of HIV-1-uninfected adults: AIDS Vaccine Evaluation Group Protocol 022A.

+ cite this

+ View Abstract

Gupta K, Hudgens M, Corey L, McElrath MJ, Weinhold K, Montefiori DC, Gorse GJ, Frey SE, Keefer MC, Evans TG, Dolin R, Schwartz DH, Harro C, Graham B, Spearman PW, Mulligan M,

(show remaining authors)

Journal of acquired immune deficiency syndromes (1999) 29(3):254-61, 2002 Mar 1 - Who cited this? | PubMed ID: 11873074 | Fulltext

Safety and immunogenicity of varying dosages of trivalent inactivated influenza vaccine administered by needle-free jet injectors.

+ cite this

+ View Abstract

Jackson LA, Austin G, Chen RT, Stout R, DeStefano F, Gorse GJ, Newman FK, Yu O, Weniger BG, and Vaccine Safety Datalink Study Group

Vaccine 19(32):4703-9, 2001 Sep 14 - Who cited this? | PubMed ID: 11535320 | Fulltext

Canarypox vaccines induce antigen-specific human gammadelta T cells capable of interferon-gamma production.

+ cite this

+ View Abstract

Worku S, Gorse GJ, Belshe RB, and Hoft DF

The Journal of infectious diseases 184(5):525-32, 2001 Sep 1 - Who cited this? | PubMed ID: 11474428 | Fulltext

HIV type 1 vaccine-induced T cell memory and cytotoxic T lymphocyte responses in HIV type 1-uninfected volunteers.

+ cite this

+ View Abstract

Gorse GJ, Patel GB, Belshe RB, and National Institute of Allergy and Infectious Diseases HIV Vaccine Trials Network

AIDS research and human retroviruses 17(12):1175-89, 2001 Aug 10 - Who cited this? | PubMed ID: 11522187 | Fulltext

Safety and immunogenicity of a canarypox-vectored human immunodeficiency virus Type 1 vaccine with or without gp120: a phase 2 study in higher- and lower-risk volunteers.

+ cite this

+ View Abstract

Belshe RB, Stevens C, Gorse GJ, Buchbinder S, Weinhold K, Sheppard H, Stablein D, Self S, McNamara J, Frey S, Flores J, Excler JL, Klein M, Habib RE, Duliege AM, Harro C,

(show remaining authors)

The Journal of infectious diseases 183(9):1343-52, 2001 May 1 - Who cited this? | PubMed ID: 11294665 | Fulltext

QS-21 promotes an adjuvant effect allowing for reduced antigen dose during HIV-1 envelope subunit immunization in humans.

+ cite this

+ View Abstract

Evans TG, McElrath MJ, Matthews T, Montefiori D, Weinhold K, Wolff M, Keefer MC, Kallas EG, Corey L, Gorse GJ, Belshe R, Graham BS, Spearman PW, Schwartz D, Mulligan MJ, Goepfert P,

(show remaining authors)

Vaccine 19(15-16):2080-91, 2001 Feb 28 - Who cited this? | PubMed ID: 11228380 | Fulltext

Cytokine responses to human immunodeficiency virus type 1 (HIV-1) induced by immunization with live recombinant canarypox virus vaccine expressing HIV-1 genes boosted by HIV-1(SF-2) recombinant GP120.

+ cite this

+ View Abstract

Gorse GJ, Patel GB, Mandava MD, Arbuckle JA, Doyle TM, Belshe RB, and National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group

Vaccine 19(13-14):1806-19, 2001 Feb 8 - Who cited this? | PubMed ID: 11166906 | Fulltext

Vaccine-induced cytotoxic T lymphocytes against human immunodeficiency virus type 1 using two complementary in vitro stimulation strategies.

+ cite this

+ View Abstract

Gorse GJ, Patel GB, Mandava MD, and Belshe RB

Vaccine 18(9-10):835-49, 1999 Dec 10 - Who cited this? | PubMed ID: 10580197 | Fulltext

Immunization with envelope MN rgp120 vaccine in human immunodeficiency virus-infected pregnant women.

+ cite this

+ View Abstract

Wright PF, Lambert JS, Gorse GJ, Hsieh RH, McElrath MJ, Weinhold K, Wara DW, Anderson EL, Keefer MC, Jackson S, Wagner LJ, Francis DP, Fast PE, and McNamara J

The Journal of infectious diseases 180(4):1080-8, 1999 Oct - Who cited this? | PubMed ID: 10479134 | Fulltext

A canarypox vaccine expressing multiple human immunodeficiency virus type 1 genes given alone or with rgp120 elicits broad and durable CD8+ cytotoxic T lymphocyte responses in seronegative volunteers.

+ cite this

+ View Abstract

Evans TG, Keefer MC, Weinhold KJ, Wolff M, Montefiori D, Gorse GJ, Graham BS, McElrath MJ, Clements-Mann ML, Mulligan MJ, Fast P, Walker MC, Excler JL, Duliege AM, and Tartaglia J

The Journal of infectious diseases 180(2):290-8, 1999 Aug - Who cited this? | PubMed ID: 10395842 | Fulltext

Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial.

+ cite this

+ View Abstract

Nichol KL, Mendelman PM, Mallon KP, Jackson LA, Gorse GJ, Belshe RB, Glezen WP, and Wittes J

JAMA : the journal of the American Medical Association 282(2):137, 1999 Jul 14 - Who cited this? | PubMed ID: 10411194 | Fulltext

MN and IIIB recombinant glycoprotein 120 vaccine-induced binding antibodies to native envelope glycoprotein of human immunodeficiency virus type 1 primary isolates. National Institute of Allergy and Infectious Disease Aids Vaccine Evaluation Group.

+ cite this

+ View Abstract

Gorse GJ, Patel GB, Mandava M, Berman PW, and Belshe RB

AIDS research and human retroviruses 15(10):921-30, 1999 Jul 1 - Who cited this? | PubMed ID: 10408729 | Fulltext

HIV-1MN recombinant glycoprotein 160 vaccine-induced cellular and humoral immunity boosted by HIV-1MN recombinant glycoprotein 120 vaccine. National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group.

+ cite this

+ View Abstract

Gorse GJ, Corey L, Patel GB, Mandava M, Hsieh RH, Matthews TJ, Walker MC, McElrath MJ, Berman PW, Eibl MM, and Belshe RB

AIDS research and human retroviruses 15(2):115-32, 1999 Jan 20 - Who cited this? | PubMed ID: 10029244 | Fulltext

Induction of immune responses to HIV-1 by canarypox virus (ALVAC) HIV-1 and gp120 SF-2 recombinant vaccines in uninfected volunteers. NIAID AIDS Vaccine Evaluation Group.

+ cite this

+ View Abstract

Belshe RB, Gorse GJ, Mulligan MJ, Evans TG, Keefer MC, Excler JL, Duliege AM, Tartaglia J, Cox WI, McNamara J, Hwang KL, Bradney A, Montefiori D, and Weinhold KJ

AIDS (London, England) 12(18):2407-15, 1998 Dec 24 - Who cited this? | PubMed ID: 9875578 | Fulltext

Advancing AIDSVAX to phase 3. Safety, immunogenicity, and plans for phase 3.

+ cite this

+ View Abstract

Francis DP, Gregory T, McElrath MJ, Belshe RB, Gorse GJ, Migasena S, Kitayaporn D, Pitisuttitham P, Matthews T, Schwartz DH, and Berman PW

AIDS research and human retroviruses 14 Suppl 3:S325-31, 1998 Oct - Who cited this? | PubMed ID: 9814961 | Fulltext

Immune responses to human immunodeficiency virus (HIV) type 1 induced by canarypox expressing HIV-1MN gp120, HIV-1SF2 recombinant gp120, or both vaccines in seronegative adults. NIAID AIDS Vaccine Evaluation Group.

+ cite this

+ View Abstract

Clements-Mann ML, Weinhold K, Matthews TJ, Graham BS, Gorse GJ, Keefer MC, McElrath MJ, Hsieh RH, Mestecky J, Zolla-Pazner S, Mascola J, Schwartz D, Siliciano R, Corey L, Wright PF, Belshe R,

(show remaining authors)

The Journal of infectious diseases 177(5):1230-46, 1998 May - Who cited this? | PubMed ID: 9593008 | Fulltext

Modulation of immunologic responses to HIV-1MN recombinant gp160 vaccine by dose and schedule of administration. National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group.

+ cite this

+ View Abstract

Gorse GJ, McElrath MJ, Matthews TJ, Hsieh RH, Belshe RB, Corey L, Frey SE, Kennedy DJ, Walker MC, and Eibl MM

Vaccine 16(5):493-506, 1998 Mar - Who cited this? | PubMed ID: 9491504 | Fulltext

Analysis of intercurrent human immunodeficiency virus type 1 infections in phase I and II trials of candidate AIDS vaccines. AIDS Vaccine Evaluation Group, and the Correlates of HIV Immune Protection Group.

+ cite this

+ View Abstract

Graham BS, McElrath MJ, Connor RI, Schwartz DH, Gorse GJ, Keefer MC, Mulligan MJ, Matthews TJ, Wolinsky SM, Montefiori DC, Vermund SH, Lambert JS, Corey L, Belshe RB, Dolin R, Wright PF,

(show remaining authors)

The Journal of infectious diseases 177(2):310-9, 1998 Feb - Who cited this? | PubMed ID: 9466516 | Fulltext

Influenza virus vaccination of patients with chronic lung disease.

+ cite this

+ View Abstract

Gorse GJ, Otto EE, Daughaday CC, Newman FK, Eickhoff CS, Powers DC, and Lusk RH

Chest 112(5):1221-33, 1997 Nov 5 - Who cited this? | PubMed ID: 9367461 | Fulltext

Safety profile of phase I and II preventive HIV type 1 envelope vaccination: experience of the NIAID AIDS Vaccine Evaluation Group.

+ cite this

+ View Abstract

Keefer MC, Wolff M, Gorse GJ, Graham BS, Corey L, Clements-Mann ML, Verani-Ketter N, Erb S, Smith CM, Belshe RB, Wagner LJ, McElrath MJ, Schwartz DH, and Fast P

AIDS research and human retroviruses 13(14):1163-77, 1997 Sep 20 - Who cited this? | PubMed ID: 9310283 | Fulltext

Vaccine-specific antibody responses induced by HIV-1 envelope subunit vaccines.

+ cite this

+ View Abstract

Pincus SH, Messer KG, Cole R, Ireland R, VanCott TC, Pinter A, Schwartz DH, Graham BS, and Gorse GJ

Journal of immunology (Baltimore, Md. : 1950) 158(7):3511-20, 1997 Apr 1 - Who cited this? | PubMed ID: 9120313 | Fulltext

Salivary binding antibodies induced by human immunodeficiency virus type 1 recombinant gp120 vaccine. The NIAID AIDS Vaccine Evaluation Group.

+ cite this

+ View Abstract

Gorse GJ, Yang EY, Belshe RB, and Berman PW

Clinical and diagnostic laboratory immunology 3(6):769-73, 1996 Nov - Who cited this? | PubMed ID: 8914773 | Fulltext

Safety and immunogenicity of a candidate HIV-1 vaccine in healthy adults: recombinant glycoprotein (rgp) 120. A randomized, double-blind trial. NIAID AIDS Vaccine Evaluation Group.

+ cite this

+ View Abstract

Graham BS, Keefer MC, McElrath MJ, Gorse GJ, Schwartz DH, Weinhold K, Matthews TJ, Esterlitz JR, Sinangil F, and Fast PE

Annals of internal medicine 125(4):270-9, 1996 Aug 15 - Who cited this? | PubMed ID: 8678389 | Fulltext

Antibody to native human immunodeficiency virus type 1 envelope glycoproteins induced by IIIB and MN recombinant gp120 vaccines. The NIAID AIDS Vaccine Evaluation Group.

+ cite this

+ View Abstract

Gorse GJ, Patel GB, Newman FK, Belshe RB, Berman PW, Gregory TJ, and Matthews TJ

Clinical and diagnostic laboratory immunology 3(4):378-86, 1996 Jul - Who cited this? | PubMed ID: 8807200 | Fulltext

Induction of mucosal antibodies by live attenuated and inactivated influenza virus vaccines in the chronically ill elderly.

+ cite this

+ View Abstract

Gorse GJ, Otto EE, Powers DC, Chambers GW, Eickhoff CS, and Newman FK

The Journal of infectious diseases 173(2):285-90, 1996 Feb - Who cited this? | PubMed ID: 8568287 | Fulltext

A dose-ranging study of a prototype synthetic HIV-1MN V3 branched peptide vaccine. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group.

+ cite this

+ View Abstract

Gorse GJ, Keefer MC, Belshe RB, Matthews TJ, Forrest BD, Hsieh RH, Koff WC, Hanson CV, Dolin R, Weinhold KJ, Frey SE, Ketter N, and Fast PE

The Journal of infectious diseases 173(2):330-9, 1996 Feb - Who cited this? | PubMed ID: 8568293 | Fulltext

Immunization with envelope subunit vaccine products elicits neutralizing antibodies against laboratory-adapted but not primary isolates of human immunodeficiency virus type 1. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group.

+ cite this

+ View Abstract

Mascola JR, Snyder SW, Weislow OS, Belay SM, Belshe RB, Schwartz DH, Clements ML, Dolin R, Graham BS, Gorse GJ, Keefer MC, McElrath MJ, Walker MC, Wagner KF, McNeil JG, McCutchan FE,

(show remaining authors)

The Journal of infectious diseases 173(2):340-8, 1996 Feb - Who cited this? | PubMed ID: 8568294 | Fulltext

Recombinant gp160 vaccination schedule and MHC HLA type as factors influencing cellular responses to HIV-1 envelope glycoprotein. NIAID AIDS Vaccine Clinical Trials Network.

+ cite this

+ View Abstract

Gorse GJ, Patel GB, Newman FK, Mandava M, and Belshe RB

Vaccine 13(13):1170-9, 1995 Sep - Who cited this? | PubMed ID: 8578800 | Fulltext

Increased anti-influenza A virus cytotoxic T cell activity following vaccination of the chronically ill elderly with live attenuated or inactivated influenza virus vaccine.

+ cite this

+ View Abstract

Gorse GJ, Campbell MJ, Otto EE, Powers DC, Chambers GW, and Newman FK

The Journal of infectious diseases 172(1):1-10, 1995 Jul - Who cited this? | PubMed ID: 7797897 | Fulltext

HIV-1 recombinant gp160 vaccine induced antibodies in serum and saliva. The NIAID AIDS Vaccine Clinical Trials Network.

+ cite this

+ View Abstract

Gorse GJ, Rogers JH, Perry JE, Newman FK, Frey SE, Patel GB, and Belshe RB

Vaccine 13(2):209-14, 1995 Feb - Who cited this? | PubMed ID: 7625118 | Fulltext

HIV-1 recombinant gp160 vaccine given in accelerated dose schedules. NIAID AIDS Vaccine Clinical Trials Network.

+ cite this

+ View Abstract

Gorse GJ, Schwartz DH, Graham BS, Matthews TJ, Stablein DM, Frey SE, Belshe RB, Clements ML, Wright PF, and Eibl M

Clinical and experimental immunology 98(2):178-84, 1994 Nov - Who cited this? | PubMed ID: 7955519 | Fulltext

Determinants of antibody response after recombinant gp160 boosting in vaccinia-naive volunteers primed with gp160-recombinant vaccinia virus. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Clinical Trials Network.

+ cite this

+ View Abstract

Graham BS, Gorse GJ, Schwartz DH, Keefer MC, McElrath MJ, Matthews TJ, Wright PF, Belshe RB, Clements ML, and Dolin R

The Journal of infectious diseases 170(4):782-6, 1994 Oct - Who cited this? | PubMed ID: 7930718 | Fulltext

Neutralizing antibodies to HIV-1 in seronegative volunteers immunized with recombinant gp120 from the MN strain of HIV-1. NIAID AIDS Vaccine Clinical Trials Network.

+ cite this

+ View Abstract

Belshe RB, Graham BS, Keefer MC, Gorse GJ, Wright P, Dolin R, Matthews T, Weinhold K, Bolognesi DP, and Sposto R

JAMA : the journal of the American Medical Association 272(6):475-80, 1994 Aug 10 - Who cited this? | PubMed ID: 7913731 | Fulltext

Vaccine-induced antibodies to native and recombinant human immunodeficiency virus type 1 envelope glycoproteins. NIAID AIDS Vaccine Clinical Trials Network.

+ cite this

+ View Abstract

Gorse GJ, Frey SE, Patel G, Newman FK, and Belshe RB

Vaccine 12(10):912-8, 1994 Aug - Who cited this? | PubMed ID: 7975833 | Fulltext

Phase I/II trials of preventive HIV vaccine candidates. Dose and schedule: summary.

+ cite this

Gorse GJ

AIDS research and human retroviruses 10 Suppl 2:S141-3, 1994 - Who cited this? | PubMed ID: 7865289 | Fulltext

Safety and immunogenicity of a fully glycosylated recombinant gp160 human immunodeficiency virus type 1 vaccine in subjects at low risk of infection. National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group Network.

+ cite this

+ View Abstract

Belshe RB, Clements ML, Dolin R, Graham BS, McElrath J, Gorse GJ, Schwartz D, Keefer MC, Wright P, and Corey L

The Journal of infectious diseases 168(6):1387-95, 1993 Dec - Who cited this? | PubMed ID: 8245523 | Fulltext

Search Google Scholar for Gorse GJ

Join Labmeeting

Organize and search your PDF collection
Collect papers
Search millions of papers
Keep up to date with paper alerts
Read your papers from anywhere
Recommend papers to colleagues
Manage your lab

Labmeeting is a web service for researchers. Sign up with your academic email address.

Individuals or corporations not affiliated with an academic institution can request a trial subscription.